8th Annual DDR Inhibitors Summit

The DDR Inhibitors Summit is a pivotal gathering for professionals in oncology drug development, focusing on the role of DNA Damage Response (DDR) inhibitors in advancing cancer therapies. This event convenes leading researchers, clinicians, and pharmaceutical innovators to discuss breakthroughs in DDR science, drug development strategies, and clinical applications. From exploring novel mechanisms of action to addressing resistance challenges, the summit offers deep insights into this rapidly evolving field. Through engaging panel discussions, cutting-edge case studies, and collaborative workshops, participants will uncover actionable strategies to accelerate DDR inhibitor development. Attendees will gain unparalleled opportunities to network with industry leaders, share knowledge, and foster collaborations that drive progress in targeted oncology treatments. This summit is an essential platform for shaping the future of cancer therapeutics.